NASDAQ:COGT | Free Cash Flow | Cogent Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$86.88M$449,000.00-$87.33M
2025-12-31-$79.11M$811,000.00-$79.92M
2025-03-31-$66.51M$547,000.00-$67.06M
2024-12-31-$60.58M$75,000.00-$60.65M
2024-03-31-$52.53M$70,000.00-$52.6M
2023-12-31-$44.07M$315,000.00-$44.39M
2023-03-31-$39.52M$1.1M-$40.62M
2022-12-31-$29.41M$1.97M-$31.38M
2022-03-31-$28.33M$441,000.00-$28.78M
2021-12-31-$20.78M$433,000.00-$21.21M
2021-03-31-$11.37M
2020-12-31-$9.37M
2020-03-31-$7.89M
2019-12-31-$8.45M$13,000.00-$8.46M-368.22%
2019-03-31-$11.52M$42,000.00-$11.56M
2018-12-31-$9.02M$0.00-$9.02M
2018-03-31-$7.98M$75,000.00-$8.06M
2017-12-31-$6.52M$100,000.00-$6.62M
2017-03-31-$7.27M$320,000.00-$7.59M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$264.44M$1.55M-$266M
2024-12-31-$207.79M$573,000.00-$208.36M
2023-12-31-$153.62M$2.8M-$156.42M
2022-12-31-$118.64M$6.86M-$125.5M
2021-12-31-$58.76M$1.72M-$60.48M
2020-12-31-$35.85M
2019-12-31-$41.51M$33,000.00-$41.55M
2018-12-31-$32.49M$549,000.00-$33.04M
2017-12-31-$25.84M$912,000.00-$26.75M